Literature DB >> 7046421

Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.

D I Bernstein, J M Zahradnik, C J DeAngelis, J D Cherry.   

Abstract

Clinical reactions and hemagglutinating-inhibiting (HAI) antibody responses to recent whole-virus and split-product influenza vaccines were studied in 168 children and young adults. The subjects initially received a monovalent vaccine, followed one month later by a trivalent preparation. The reactogenicity of whole-virus and split-product vaccines with an equivalent hemagglutinin content was similar except in the youngest age (6 to 36 months) group in which the whole-virus preparation was more reactogenic. The whole-virus vaccines were more immunogenic, especially in subjects who were previously unprimed (preimmunization HAI antibody titer, less than 5). In these subjects, the geometric mean titers of HAI antibody wee significantly higher after vaccination with whole-virus vaccines than the split-product vaccines. Specific IgM antibody was found more frequently after vaccination with whole-virus vaccines (34%) than after split-product vaccines (11%).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7046421

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  3 in total

Review 1.  Vaccines for preventing influenza in people with cystic fibrosis.

Authors:  Poonam Dharmaraj; Rosalind L Smyth
Journal:  Cochrane Database Syst Rev       Date:  2014-03-06

2.  Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses.

Authors:  Mark G Thompson; Jessie Clippard; Joshua G Petrie; Michael L Jackson; Huong Q McLean; Manjusha Gaglani; Evelyn C Reis; Brendan Flannery; Arnold S Monto; Lisa Jackson; Edward A Belongia; Kempapura Murthy; Richard K Zimmerman; Swathi Thaker; Alicia M Fry
Journal:  Pediatr Infect Dis J       Date:  2016-03       Impact factor: 2.129

3.  Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.

Authors:  Varsha K Jain; Joseph B Domachowske; Long Wang; Opokua Ofori-Anyinam; Miguel A Rodríguez-Weber; Michael L Leonardi; Nicola P Klein; Gary Schlichter; Robert Jeanfreau; Byron L Haney; Laurence Chu; Jo-Ann S Harris; Kwabena O Sarpong; Amanda C Micucio; Jyoti Soni; Vijayalakshmi Chandrasekaran; Ping Li; Bruce L Innis
Journal:  J Pediatric Infect Dis Soc       Date:  2017-03-01       Impact factor: 3.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.